| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_951ade9cb9f29eb8a29ddae1e2fc87e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2007-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1793563c8d136011e0fec25263aa1e76 |
| publicationDate |
2009-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090028047-A |
| titleOfInvention |
New Uses of Dimethylfumarate |
| abstract |
The present invention provides a pharmaceutical composition for inhibiting vascular smooth muscle cell proliferation, comprising dimethyl fumarate as an active ingredient, a method for inhibiting vascular smooth muscle cell proliferation of dimethyl fumarate, and a method for inhibiting vascular smooth muscle cell proliferation using the same.n n n Through the present invention, it was found that dimethyl fumarate can inhibit the proliferation of vascular smooth muscle cells by increasing the activity of AMPK. Therefore, dimethyl fumarate can be usefully used as an active ingredient of medicine for inhibiting vascular smooth muscle cell proliferation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014126285-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101379427-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200138005-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020242132-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220133807-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9724320-B2 |
| priorityDate |
2007-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |